DNA sources from liquid biopsies correlate to track MM progress

A paper published in Nature Communications showed concordance between sequencing of circulating free DNA (cfDNA) and circulating tumor cell (CTC) DNA, suggesting the methods could replace bone marrow biopsies to genetically monitor multiple myeloma patients.

Bone marrow biopsies are the established standard for diagnosing and tracking multiple myeloma, but are too invasive for frequent testing...